{
  "DOI": "10.1086/422366",
  "ISSN": [
    "0002-9297"
  ],
  "URL": "http://dx.doi.org/10.1086/422366",
  "alternative-id": [
    "S0002929707619946"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Wilcox",
      "given": "William R.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "name": "for the International Fabry Disease Study Group",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Banikazemi",
      "given": "Maryam",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guffon",
      "given": "Nathalie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Waldek",
      "given": "Stephen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lee",
      "given": "Philip",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Linthorst",
      "given": "Gabor E.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Desnick",
      "given": "Robert J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Germain",
      "given": "Dominique P.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "The American Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2004,
        6,
        2
      ]
    ],
    "date-time": "2004-06-02T21:52:12Z",
    "timestamp": 1086213132000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        4,
        2
      ]
    ],
    "date-time": "2020-04-02T09:47:50Z",
    "timestamp": 1585820870000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        20
      ]
    ],
    "date-time": "2024-04-20T09:52:05Z",
    "timestamp": 1713606725106
  },
  "is-referenced-by-count": 319,
  "issn-type": [
    {
      "type": "print",
      "value": "0002-9297"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2004,
        7
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2004,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2004,
            7,
            1
          ]
        ],
        "date-time": "2004-07-01T00:00:00Z",
        "timestamp": 1088640000000
      }
    },
    {
      "URL": "https://www.elsevier.com/open-access/userlicense/1.0/",
      "content-version": "vor",
      "delay-in-days": 3305,
      "start": {
        "date-parts": [
          [
            2013,
            7,
            19
          ]
        ],
        "date-time": "2013-07-19T00:00:00Z",
        "timestamp": 1374192000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0002929707619946?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0002929707619946?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "member": "78",
  "page": "65-74",
  "prefix": "10.1016",
  "published": {
    "date-parts": [
      [
        2004,
        7
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2004,
        7
      ]
    ]
  },
  "publisher": "Elsevier BV",
  "reference": [
    {
      "DOI": "10.1097/00005792-200203000-00003",
      "article-title": "Natural history of Fabry renal disease: influence of α-galactosidase A activity and genetic mutations on clinical course",
      "author": "Branton",
      "doi-asserted-by": "crossref",
      "first-page": "122",
      "journal-title": "Medicine (Baltimore)",
      "key": "10.1086/422366_bib3",
      "volume": "81",
      "year": "2002"
    },
    {
      "article-title": "Angiokeratoma corporis diffusum: Fabry’s disease",
      "author": "Colombi",
      "first-page": "67",
      "journal-title": "Helv Med Acta",
      "key": "10.1086/422366_bib4",
      "volume": "34",
      "year": "1967"
    },
    {
      "DOI": "10.1093/ndt/18.1.33",
      "article-title": "Enzyme replacement therapy in Anderson-Fabry’s disease: beneficial clinical effect on vital organ function",
      "author": "De Schoenmakere",
      "doi-asserted-by": "crossref",
      "first-page": "33",
      "journal-title": "Nephrol Dial Transplant",
      "key": "10.1086/422366_bib5",
      "volume": "18",
      "year": "2003"
    },
    {
      "DOI": "10.7326/0003-4819-138-4-200302180-00014",
      "article-title": "Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy",
      "author": "Desnick",
      "doi-asserted-by": "crossref",
      "first-page": "338",
      "journal-title": "Ann Intern Med",
      "key": "10.1086/422366_bib6",
      "volume": "138",
      "year": "2003"
    },
    {
      "article-title": "α-Galactosidase A deficiency: Fabry disease",
      "author": "Desnick",
      "first-page": "3733",
      "key": "10.1086/422366_bib7",
      "series-title": "The metabolic and molecular bases of inherited disease",
      "year": "2001"
    },
    {
      "DOI": "10.1086/318809",
      "article-title": "A phase 1/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies",
      "author": "Eng",
      "doi-asserted-by": "crossref",
      "first-page": "711",
      "journal-title": "Am J Hum Genet",
      "key": "10.1086/422366_bib8",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1056/NEJM200107053450102",
      "article-title": "Safety and efficacy of recombinant human α-galactosidase A replacement therapy in Fabry’s disease",
      "author": "Eng",
      "doi-asserted-by": "crossref",
      "first-page": "9",
      "journal-title": "N Eng J Med",
      "key": "10.1086/422366_bib9",
      "volume": "345",
      "year": "2001"
    },
    {
      "DOI": "10.1023/B:BOLI.0000028726.11177.8b",
      "doi-asserted-by": "crossref",
      "key": "10.1086/422366_bib10",
      "unstructured": "Guffon N, Fouilhoux A. Clinical benefit in Fabry patients given enzyme replacement therapy: a case series. J Inherit Metab Dis, in press"
    },
    {
      "article-title": "A simplified equation to predict glomerular filtration rate from serum creatinine",
      "author": "Levey",
      "first-page": "155A",
      "journal-title": "J Am Soc Nephrol",
      "key": "10.1086/422366_bib11",
      "volume": "11",
      "year": "2000"
    },
    {
      "DOI": "10.1136/jmg.38.11.750",
      "article-title": "Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males",
      "author": "MacDermot",
      "doi-asserted-by": "crossref",
      "first-page": "750",
      "journal-title": "J Med Genet",
      "key": "10.1086/422366_bib12",
      "volume": "38",
      "year": "2001"
    },
    {
      "DOI": "10.1016/0304-3959(87)91074-8",
      "article-title": "The short-form McGill pain questionnaire",
      "author": "Melzack",
      "doi-asserted-by": "crossref",
      "first-page": "191",
      "journal-title": "Pain",
      "key": "10.1086/422366_bib13",
      "volume": "30",
      "year": "1987"
    },
    {
      "DOI": "10.1182/blood.V82.5.1402.1402",
      "article-title": "Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase",
      "author": "Richards",
      "doi-asserted-by": "crossref",
      "first-page": "1402",
      "journal-title": "Blood",
      "key": "10.1086/422366_bib14",
      "volume": "82",
      "year": "1993"
    },
    {
      "DOI": "10.1182/blood.V93.6.2081.406k07_2081_2088",
      "article-title": "Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: induction of humoral tolerance in seroconverted patients after repeat administration",
      "author": "Rosenberg",
      "doi-asserted-by": "crossref",
      "first-page": "2081",
      "journal-title": "Blood",
      "key": "10.1086/422366_bib15",
      "volume": "93",
      "year": "1999"
    },
    {
      "DOI": "10.1073/pnas.97.1.365",
      "article-title": "Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease",
      "author": "Schiffmann",
      "doi-asserted-by": "crossref",
      "first-page": "365",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "10.1086/422366_bib16",
      "volume": "97",
      "year": "2000"
    },
    {
      "DOI": "10.1046/j.1523-1755.2002.00097.x",
      "article-title": "Patients with Fabry disease on dialysis in the United States",
      "author": "Thadhani",
      "doi-asserted-by": "crossref",
      "first-page": "249",
      "journal-title": "Kidney Int",
      "key": "10.1086/422366_bib17",
      "volume": "61",
      "year": "2002"
    },
    {
      "DOI": "10.1046/j.1523-1755.2002.00675.x",
      "article-title": "Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy",
      "author": "Thurberg",
      "doi-asserted-by": "crossref",
      "first-page": "1933",
      "journal-title": "Kidney Int",
      "key": "10.1086/422366_bib18",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1056/NEJM200303203481224",
      "article-title": "PR interval and the response to enzyme-replacement therapy for Fabry’s disease",
      "author": "Waldek",
      "doi-asserted-by": "crossref",
      "first-page": "1186",
      "journal-title": "N Engl J Med",
      "key": "10.1086/422366_bib19",
      "volume": "348",
      "year": "2003"
    },
    {
      "author": "Ware",
      "key": "10.1086/422366_bib20",
      "series-title": "SF-36 health survey manual and interpretation guide",
      "year": "1997"
    },
    {
      "DOI": "10.1161/01.CIR.0000091253.71282.04",
      "article-title": "Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study",
      "author": "Weidemann",
      "doi-asserted-by": "crossref",
      "first-page": "1299",
      "journal-title": "Circulation",
      "key": "10.1086/422366_bib21",
      "volume": "108",
      "year": "2003"
    },
    {
      "DOI": "10.1006/abio.1998.2966",
      "article-title": "Quantitative determination of globotriaosylceramide by immunodetection of glycolipid-bound recombinant verotoxin B subunit",
      "author": "Zeidner",
      "doi-asserted-by": "crossref",
      "first-page": "104",
      "journal-title": "Anal Biochem",
      "key": "10.1086/422366_bib22",
      "volume": "267",
      "year": "1999"
    }
  ],
  "reference-count": 20,
  "references-count": 20,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0002929707619946"
    }
  },
  "score": 0,
  "short-container-title": [
    "The American Journal of Human Genetics"
  ],
  "source": "Crossref",
  "title": [
    "Long-Term Safety and Efficacy of Enzyme Replacement Therapyfor Fabry Disease"
  ],
  "type": "journal-article",
  "volume": "75"
}